Genentech Resists Takeover
Friday, March 6, 2009 - 09:49
in Mathematics & Economics
Executives focus on Avastin's potential in spurning Roche's hostile offer of $86.50
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via